The data is deposited in our institutional repository, and are freely available: <http://datacompass.lshtm.ac.uk/>. The DOI for the two datasets is: DOI: [10.17037/DATA.116](http://dx.doi.org/10.17037/DATA.116).

Introduction {#sec005}
============

1.1 Conceptualising disability {#sec006}
------------------------------

The conceptualisation of disability is complex and has evolved over time. Initially, disability was viewed as a purely medical phenomenon determined by an individual having an impairment in body functioning or structure (e.g. the presence of mobility or visual impairments) \[[@pone.0164470.ref001]\]. Later, the Social Model framed disability as resulting from external restrictions placed by society on people with impairments \[[@pone.0164470.ref002]\], for instance, through inaccessible buildings reducing the options for people with physical impairments to work. The prevailing framework is the International Classification of Functioning, Disability and Health (ICF), developed by the World Health Organisation (WHO) in 2001 \[[@pone.0164470.ref003]--[@pone.0164470.ref007]\]. The ICF ([Fig 1](#pone.0164470.g001){ref-type="fig"}) is considered a *bio-psycho-social* model of disability, which refers to dysfunctioning in one of three interlinked levels--impairments in body function or structure, activity limitations, or participation restrictions--and is the result of an interaction between a health condition and contextual factors.

![The ICF.](pone.0164470.g001){#pone.0164470.g001}

For example, the disease poliomyelitis (health condition) may affect leg muscle weakness (body function and structure) limiting the individual's ability to walk (activities) and thus attend school (participation restrictions). This "dysfunctioning" can be mediated by environmental factors (e.g. assistive devices) and personal factors (e.g. family support).

1.2 Approaches to measuring disability within the ICF {#sec007}
-----------------------------------------------------

Disability data based on the ICF are crucial for appropriate service-planning and evidence-based advocacy. Despite this, few robust population-level disability surveys exist globally. Amongst those that do, non-comparable and non-comprehensive methodologies are used \[[@pone.0164470.ref008]\].

There are three broad measurement approaches in disability. The most rapid is direct questioning, e.g. "Do you consider yourself to have a disability?" \[[@pone.0164470.ref009], [@pone.0164470.ref010]\]. This leads to substantial under-reporting, due to stigma and cultural perceptions of disability, and is not considered adequate \[[@pone.0164470.ref001], [@pone.0164470.ref011]\].

A second approach is to ask people to report whether they experience activity limitations in core domains of function e.g. whether they have difficulties in seeing or hearing \[[@pone.0164470.ref012], [@pone.0164470.ref013]\]. This approach focuses on the "activities" component of the ICF. The method recognises the spectrum of functional limitations people with the same impairment may have and maximises the information that can be garnered at low cost. In addition, the use of scaled response options allows estimation of the continuum of functional difficulties in the population \[[@pone.0164470.ref014], [@pone.0164470.ref015]\].

Efforts to assess disability status in this way includes work by several international organisations. The Washington Group on Disability Statistics was established as a United Nations Statistical Commission City Group in 2001, and has developed a short and extended set of questions on functioning for adults, and a functioning module for children aged 2--17 \[[@pone.0164470.ref013], [@pone.0164470.ref016]\]. The WHO have produced the WHO Disability Assessment Schedule (WHODAS) to measure and assess disability and health in relation to the ICF, and more recently, the Model Disability Survey (MDS), in collaboration with the World Bank \[[@pone.0164470.ref017], [@pone.0164470.ref018]\].

A third methodology is to objectively measure clinical impairments or the presence of specific, potentially disabling health conditions, e.g. visual acuity or seizure history. This approach focuses on objectively determining whether the individual has impairments or health conditions that affect the "body function and structure" component of the ICF. Objective screening criteria on cause and severity can aid service planning and produces reliable and comparable data \[[@pone.0164470.ref011]\]. However, impairment data alone do not capture how the individual functions in his or her environment (i.e. activity limitations and participation restrictions) and the overall disability experience. Additionally, impairment surveys have typically focussed on one impairment only and are comparatively expensive to conduct through reliance on clinical examiners and specialist equipment.

Comprehensive surveys of disability that assess both reported activity/functional limitations and clinical impairments or health conditions are absent from the literature. The aim of this study was to explore the interaction between measures of clinical impairment and reported functional limitation in estimating disability prevalence within the ICF, through studies in India and Cameroon.

Methods {#sec008}
=======

2.1 Study Overview {#sec009}
------------------

We undertook a population-based disability survey in one district each of Cameroon (Fundong Health District, North-West Region, 2013) and India (Mahbubnagar District, Telengana State, 2014). We screened for disability using i) self-reported functional limitation and ii) clinical assessment of impairment (visual, hearing, musculoskeletal) and potentially disabling health conditions (epilepsy and depression).

2.2 Survey Population and Sampling {#sec010}
----------------------------------

We conservatively estimated the all-age prevalence of disability (defined for this study as self-reported limitations and/or presence of moderate or greater clinical impairment, epilepsy or depression) to be 4% in both India and Cameroon \[[@pone.0164470.ref008], [@pone.0164470.ref019]\]. This required a sample of 4,056 per country, assuming precision of 20%, 95% confidence, a design effect of 1.4 and 20% non-response.

Using probability proportionate to size sampling, 51 clusters of 80 people were selected using the most recent census data (rural and urban units) in each country \[[@pone.0164470.ref020]--[@pone.0164470.ref022]\].Households within clusters were selected using compact segment sampling. A map of each cluster was divided into segments of approximately 80 people. One segment was randomly selected and enumerators visited each household in that segment until 80 eligible participants (permanent household members in selected households) were enumerated. Permanent household members were defined as: 1) has lived in the selected household at least six months of the last year 2) eats shared meals 3) does not pay rent to other household members.

Enumerated participants were invited to attend the survey screening at a central community location over two consecutive days. Those who were not able to attend the central location (e.g. due to mobility restriction) were examined in their homes at the end of the second day.

2.3 Screening Methodology {#sec011}
-------------------------

All participants were screened for both i) self-reported functional limitations and ii) clinical impairments/disabling health conditions.

Self-reported functional limitations were assessed using the Washington Group Extended Set on Functioning (ten core/ four non-core domains) and the draft UNICEF/Washington Group Extended Set on Child Functioning and Disability (eight core/ four non-core domains) with response options as described in [Table 1](#pone.0164470.t001){ref-type="table"} \[[@pone.0164470.ref014]\]\[[@pone.0164470.ref023]\]. These modules were selected following a scoping review of the literature conducted in 2013, and considered both to be the most comprehensive and the most readily comparable to clinical measures (see below). We followed the Washington Group recommended cut-off for moderate or above difficulty (at least "a lot of" difficulty in any one domain) and restricted this to core domains only\[[@pone.0164470.ref024]\]. Non-core domains in the modules included pain, fatigue, anxiety and depression, and these were excluded from the case-definition given that work to refine and field-test these questions is ongoing\[[@pone.0164470.ref025]\]. Caregivers reported for children 2--7; children aged 8--17 in India and 8--20 in Cameroon self-reported in the presence of a caregiver, unless unable to communicate directly; and adults aged 18+ in India and 21+ in Cameroon self-reported unless a proxy was needed for communication purposes.

10.1371/journal.pone.0164470.t001

###### Impairment and Health Condition Screening, Examination and Case Definition Criteria.

![](pone.0164470.t001){#pone.0164470.t001g}

                                                                                                                             Tool                                                                                                                                     Stage                                                                                                                                                             Age                                                                                                                               Method                                                                                                       Severity Thresholds
  -------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  SRFL                                                                                                                       UNICEF/ Washington Group Module on Child Functioning & Disability\[[@pone.0164470.ref023]\]                                              *Screen*                                                                                                                                                          0--1                                                                                                                              None[^1^](#t001fn002){ref-type="table-fn"}                                                                   \-
  2--7                                                                                                                       Caregiver report on 12 functional domains assessed on reported severity scale of limitation in completing activities related to domain   Response categories: i) No difficulty; ii) Some difficulty; iii) A lot of difficulty; iv) Cannot do                                                                                                                                                                                                                                                                                                              
  I: 8--17 C: 8--20                                                                                                          As above; self report in caregiver presence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  Washington Group Extended Set on Functioning \[[@pone.0164470.ref029]\]                                                    *Screen*                                                                                                                                 I: 18+ C:21+                                                                                                                                                      14 functional domains assessed on reported severity scale of limitation in completing activities related to domain; self report                                                                                                                
  V                                                                                                                          Adapted Rapid Assessment of Avoidable Blindness (RAAB) \[[@pone.0164470.ref030]\]                                                        *Screen*                                                                                                                                                          \<2                                                                                                                               Fix and Follow                                                                                               Cannot fix and follow
  2--4                                                                                                                       Finger counting                                                                                                                          Cannot count fingers                                                                                                                                                                                                                                                                                                                                                                                             
  5+                                                                                                                         Visual Acuity (VA) (presenting and pinhole if VA \<6/18) measured via tumbling 'E' chart                                                 Presenting vision in better eye: i)No impairment: VA ≥ 6/18; ii) Moderate: VA\<6/18 but ≥6/60; iii) Severe: VA \<6/60 but ≥3/60; iv) Profound (blind): VA\<3/60                                                                                                                                                                                                                                                  
  *Exam*                                                                                                                     All ages                                                                                                                                 Examination to determine cause using direct ophthalmoscope by ophthalmic nurse (Cameroon) or ophthalmic assistant (India) if meet impairment criteria                                                                                                                                                                                                                                                            
  H                                                                                                                          WHO Ear and Hearing Disorders Examination Protocol\[[@pone.0164470.ref031]\]                                                             *Screen*                                                                                                                                                          0--3                                                                                                                              Oto-Acoustic Emissions (OAE) Test                                                                            OAE Test Failure in both ears
  4+                                                                                                                         OAE Test followed by Pure Tone Audiometry if OAE fails in both ears                                                                      Audiometry reading in better ear:                                                                                                                                                                                                                                                                                                                                                                                
  Children (4--17): i) No impairment: \<35dBA; ii) Moderate: 35-60dBA; iii) Severe: 61-80dBA; iv) Profound (deaf): \>80dBA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Adults: i) No impairment: \<41dBA; ii) Moderate: 41-60dBA; iii) Severe: 61-80dBA; iv) Profound (deaf): \>80dBA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  *Exam*                                                                                                                     All ages                                                                                                                                 Otoscopy examination to determine cause by an ENT Nurse (Cameroon) or audiologist (India) if meet impairment criteria                                                                                                                                                                                                                                                                                            
  MSI                                                                                                                        Rapid Assessment of Musculoskeletal Impairment (RAM) \[[@pone.0164470.ref032]\]                                                          *Screen*                                                                                                                                                          0--7                                                                                                                              Caregiver report 6 questionss[^2^](#t001fn003){ref-type="table-fn"} followed by examination if affirmative   Physiotherapist observed effects on the ability of the musculoskeletal system to function as a whole, categorised as: i) No impairment; ii) Mild; iii) Moderate; iv) Severe
  8+                                                                                                                         As above; self report                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  *Exam*                                                                                                                     All ages                                                                                                                                 Examination by physiotherapist including standardised observation of activities                                                                                                                                                                                                                                                                                                                                  
  E                                                                                                                          (RAM) \[[@pone.0164470.ref032]\]                                                                                                         *Screen*                                                                                                                                                          0--7                                                                                                                              Caregiver report of 3 questions to assess frequency and type of seizure activity                             Reported three or more generalised tonic-clonic seizures in the past 12 months
  8+                                                                                                                         As above; self report                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  D                                                                                                                          Patient Health Questionnaire (PHQ9) \[[@pone.0164470.ref033]\]                                                                           *Screen*                                                                                                                                                          18+                                                                                                                               Three self-reported screening questions with a further six questions if screen is positive                   Composite score: i) None: 0--4; ii) Mild: 10--14; iii) Moderately Severe: 15--19; iv) Severe: 20--27

Column 1 acronyms: SRFL--self reported functional limitation; V--visual impairment; H--hearing impairment; MSI--musculoskeletal impairment; E--Epilepsy; D--depression

^1^No tools for this age group available

^2^In India, a seventh question on chronic back pain was added

Clinical impairments and two potentially disabling health conditions (epilepsy and depression) were assessed using pre-existing tools. The tool, methodology and severity threshold for each are described in [Table 1](#pone.0164470.t001){ref-type="table"}. Epilepsy was included given that-self reported tools do not include questions on seizure history. However, previous research has shown an association both between epilepsy and lower health-related quality of life, and between accidents during seizures and long term physical impairment\[[@pone.0164470.ref026]\]. To our knowledge, depression (considered one of the leading health conditions related to disability globally) is the only common mental disorder for which a clinical screen has been validated in both India and Cameroon \[[@pone.0164470.ref027], [@pone.0164470.ref028]\].

Participants identified as having a vision, hearing or musculoskeletal impairment (henceforth MSI) were examined by the relevant clinician in the team to determine cause and refer to services as appropriate. In Cameroon, each team consisted of one Ear Nose and Throat nurse, one physiotherapist or orthopaedic clinical officer, one ophthalmic nurse and seven non-clinical fieldworkers. In India, each team comprised one audiologist, one physiotherapist, one vision technician or ophthalmic assistant and seven non-clinical fieldworkers.

Mild MSI and mild hearing impairment were recorded in both settings. In India, mild visual impairment was also recorded.

2.4 Definition of disability {#sec012}
----------------------------

A participant was classified as having a disability in this study if they:

-   Screened positive to any moderate/severe clinical impairment (vision, hearing, musculoskeletal) or severe potentially disabling health condition (epilepsy or depression)--"clinical" cases.

-   Reported significant functional limitations ("a lot of difficulty" or "cannot do") in any core functional domains. Children aged 2--17 years: seeing, hearing, walking, self-care, understanding, being understood, learning, remembering; Adults 18+ years: seeing, hearing, walking or climbing steps, understanding, being understood, remembering, concentrating, self-care, upper body strength, fine motor dexterity.)--"self-reported" cases.

All participants who were classified as having a disability ("cases") were further interviewed about socio-demographics, poverty, livelihoods, education, health, water and sanitation, activities and participation.

Participation scores were generated using a question set developed by SINTEF which assesses ability to perform a range of activities in the respondents' current environment\[[@pone.0164470.ref034]\]. Domains include: self-care, domestic life, interpersonal behaviours, major life areas (school/ work) and community/civic life. Each question was scored on a response scale: "no difficulty", "moderate difficulty", "severe difficulty" and "inability to perform".

2.5 Training and translation {#sec013}
----------------------------

In India, all tools were translated into Telegu and back-translated by an independent translator. Any differences between the translated and original version were discussed and the translations were modified accordingly. The primary language in the Cameroon site was English, however the population in the study area also spoke both Pidgin English and Nkom. Interviewers were recruited who spoke all three languages, and the quality of their verbal translation into these languages was assessed: the interviewers asked the question in the local language and an independent person translated this back into English. Differences were noted and discussed, and a phonetic phrase-sheet of standard translations of terms (e.g. depression, anxiety, assets) was developed to ensure consistency. Cognitive testing of the questionnaires was then carried out in each site to assess feasibility and understanding.

Three teams per country were trained for ten days on disability sensitivity and project protocols. This included formal inter-observer variation testing of all clinical screens, and an observed practice of the full protocol on thirty volunteers.

2.6 Data Entry and Analysis {#sec014}
---------------------------

Data were analysed using STATA 12.0. The 'svy' command was used to derive prevalence estimates accounting for cluster sampling. Predictors of the agreement between the different disability measures were analysed using logistic regression. Specifically, we assessed demographic (age, sex) and impairment-related (severity, type) predictors of people with clinical impairments also reporting functional limitations. Mean participation scores among participants screening positive for the different disability measures were compared using the student t-test. Cross-tabulations were conducted to describe the relationship between i) any level reported functional limitation in seeing and any level visual impairment ii) any level reported limitation in hearing and any level hearing impairment iii) any level reported limitation in walking, climbing, upper body strength and fine motor skills and any level muscular-skeletal impairment, iv) any level of reported limitation and any level clinical impairment aggregated across the domains above.

2.7 Ethical Considerations {#sec015}
--------------------------

Ethical Approval was granted by:

-   The London School of Hygiene & Tropical Medicine (UK)

-   National Ethics Committee for Research in Human Health (CNERSH, Cameroon)

-   Cameroon Baptist Convention Health Board Institutional Review Board (Cameroon)

-   Indian Institute of Public Health Hyderabad Institutional Ethics Committee (India)

-   Government of India Health Ministry Screening Committee (India)

Medicines for minor health ailments were distributed by clinical team members where appropriate and participants with unmet health needs were referred to relevant services. Written (signature or thumb print) informed consent was obtained from all participants. Caregivers provided consent for participants \<18 years in India and \<21 years in Cameroon in accordance with country ethics.

Results {#sec016}
=======

The survey response rate was 87% in Cameroon (n = 3567) and 88% in India (n = 3574) ([Table 2](#pone.0164470.t002){ref-type="table"}). There were more females than males in the Cameroon sample (59%), in agreement with the 2005 Census (52% female)\[[@pone.0164470.ref020]\]. In India, 52% of the sample were female compared with 50% in the 2011 Census \[[@pone.0164470.ref021]\]. Consequently, the results are self-weighted.

10.1371/journal.pone.0164470.t002

###### Sample age and sex characteristics in Cameroon and India.

![](pone.0164470.t002){#pone.0164470.t002g}

           Cameroon   India                                                                                                 
  -------- ---------- -------- ---------- -------- ----------- --------- ---------- -------- ---------- -------- ---------- ---------
  0--9     609        42       630        30       1,239       35        365        21       345        18       710        19
  10--19   399        27       423        20       822         23        353        2.1      320        17       673        19
  20--29   77         5        307        15       384         11        277        16       356        19       633        18
  30--39   70         5        197        9        267         7         214        13       284        15       498        14
  40--49   67         5        152        7        219         6         185        11       207        11       392        11
  50--59   61         4        146        7        207         6         143        8        173        9        316        9
  60--69   60         4        127        6        187         5         116        7        118        6        234        7
  70--79   66         5        86         4        152         4         42         2        46         2        88         2
  80+      46         3        44         2        90          3         13         1        17         1        30         1
  Total    **1455**   **41**   **2122**   **59**   **3,567**   **100**   **1708**   **48**   **1866**   **52**   **3574**   **100**

3.1 Overall Prevalence of Disability {#sec017}
------------------------------------

The overall population prevalence of disability (defined as reporting significant functional limitations and / or having a moderate or severe clinical impairment, epilepsy or depression) was 10.5% (95% CI 9.0--12.2) in Cameroon and 12.2% (10.6--14.1) in India ([Table 3](#pone.0164470.t003){ref-type="table"}). In both countries, the prevalence was similar in women and men and increased exponentially with age.

10.1371/journal.pone.0164470.t003

###### Overall Disability Prevalence in Cameroon and India.

![](pone.0164470.t003){#pone.0164470.t003g}

                                     Cameroon   India                                                     
  ---------------------------------- ---------- ------------------- ----------------- ------------------- ------------------
  Overall Prevalence of Disability   373        10.5 (9.0--12.2)    437               12.2 (10.6--14.1)   
  Sex                                Male       144                 9.9 (8.3--11.7)   199                 11.7 (9.7--14.0)
  Female                             229        10.8 (9.0--13.0)    238               12.8 (10.9--14.8)   
  Age Group                          0--17      91                  4.7 (3.7--5.9)    44                  3.6 (2.6--4.9)
  18--49                             68         6.9 (5.3--9.1)      137               8.1 (6.0--11.0)     
  50+                                214        33.6 (28.8--38.9)   256               38.3 (33.6--43.3)   

3.2 Prevalence of Significant Functional Limitations {#sec018}
----------------------------------------------------

Significant functional limitation was reported by 5.9% of participants in Cameroon and 7.5% in India ("self-reported" cases) ([Table 4](#pone.0164470.t004){ref-type="table"}). In both countries, the most commonly reported functional limitations among children (aged 2--17) were in walking, remembering and learning. Amongst adults (18+), difficulties in walking/climbing, seeing and hearing were most commonly reported.

10.1371/journal.pone.0164470.t004

###### Reported Functional Limitations and Clinical Impairments in Cameroon and India[^1^](#t004fn001){ref-type="table-fn"}.

![](pone.0164470.t004){#pone.0164470.t004g}

                                                        Cameroon                                                      India                                                 
  ----------------------------------------------------- ------------------------------------------------------------- ---------------- ----------------- ------------------ -----------------
  Reported Functional Limitations                                                                                                                                           
  Any Reported Functional Limitation                    197                                                           5.9 (4.7--7.4)   258               7.5 (5.9--9.4)     
  Children 2--17                                        Any reported functional limitation                            44               2.6 (1.8--3.6)    25                 2.3 (1.4--3.7)
  Seeing                                                6                                                             0.4 (0.1--0.9)   3                 0.3 (0.1--1.2)     
  Hearing                                               6                                                             0.4 (0.2--0.8)   5                 0.5 (0.2--1.1)     
  Walking                                               13                                                            0.8 (0.4--1.5)   9                 0.8 (0.4--1.6)     
  Understanding                                         6                                                             0.4 (0.2--0.8)   10                0.9 (0.5--1.7)     
  Being Understood                                      7                                                             0.4 (0.2--0.9)   8                 0.7 (0.3--1.5)     
  Learning                                              11                                                            0.6 (0.3--1.2)   10                0.9 (0.4--1.9)     
  Remembering                                           15                                                            1.1 (0.6--2.0)   7                 0.8 (0.4--1.6)     
  Self-Care                                             4                                                             0.3 (0.1--0.8)   6                 0.7 (0.3--1.5)     
                                                                                                                                                                            
  Adults 18+                                            Any Reported functional limitation                            153              9.5 (7.4--12.1)   233                9.9 (7.9--12.4)
  Seeing                                                48                                                            3.0 (2.0--4.3)   85                3.6 (2.4--5.4)     
  Hearing                                               33                                                            2.0 (1.3--3.2)   86                3.7 (2.8--4.7)     
  Walking/climbing                                      89                                                            5.5 (4.1--7.3)   112               4.8 (3.6--6.2)     
  Communicating                                         7                                                             0.4 (0.2--1.0)   21                0.9 (0.6--1.4)     
  Remembering/ Concentrating                            46                                                            2.9 (1.9--4.2)   31                1.3 (0.7--2.4)     
  Self-Care                                             19                                                            1.2 (0.7--1.9)   34                1.4 (1.0--2.0)     
  Upper Body Strength                                   19                                                            1.2 (0.7--1.9)   46                2.0 (1.5--2.6)     
  Fine Motor Skills                                     14                                                            0.9 (0.5--1.5)   32                1.4 (0.8--2.2)     
  Clinical Impairments                                                                                                                                                      
  Any clinical impairment/ disabling health condition   294                                                           8.4 (7.5--9.4)   376               10.5 (9.4--11.7)   
  Vision Impairment                                     All Vision impairment[\*](#t004fn002){ref-type="table-fn"}    82               2.3 (1.8--3.0)    124                3.5 (2.7--4.4)
  Moderate                                              55                                                            1.9 (1.3--2.6)   91                2.8 (2.2--3.7)     
  Severe                                                10                                                            0.3 (0.2--0.6)   16                0.5 (0.3--0.9)     
  Profound (blind)                                      17                                                            0.6 (0.3--1.0)   14                0.4 (0.2--0.9)     
                                                                                                                                                                            
  Hearing Impairment                                    All Hearing impairment[\*](#t004fn002){ref-type="table-fn"}   127              3.6 (2.8--4.6)    157                4.4 (3.7--5.2)
  Moderate                                              76                                                            2.5 (1.9--3.2)   102               3.1 (2.4--3.8)     
  Severe                                                15                                                            0.5 (0.3--0.8)   34                1.0 (0.7--1.5)     
  Profound (deaf)                                       9                                                             0.3 (0.1--0.6)   15                0.5 (0.2--0.9)     
                                                                                                                                                                            
  Musculoskeletal Impairment                            All MSI[\*](#t004fn002){ref-type="table-fn"}                  123              3.4 (2.7--4.4)    125                3.5 (2.9--4.3)
  Moderate                                              113                                                           3.2 (2.5--4.0)   80                2.2 (1.8--2.8)     
  Severe                                                10                                                            0.3 (0.2--0.5)   44                1.2 (0.8--1.8)     
                                                                                                                                                                            
  Health Conditions and Multiple Impairments            Epilepsy                                                      25               0.7 (0.5--1.0)    63                 1.8 (1.4--2.2)
  Clinical Depression (\>17 only)                       7                                                             0.4 (0.2--0.9)   26                1.1 (0.7--1.6)     
  Multiple Impairments                                  59                                                            1.7 (1.2--2.1)   91                2.5 (2.1--3.1)     

^1^Table describes proportion of sample reporting "a lot of difficulty" or "cannot do" to any basic domain

\* "All" impairment refers to all moderate or greater impairment. Severity estimates for vision and hearing are restricted to \>4 and \>3 years respectively as severity was not determined below these age groups for each screen

3.3 Prevalence of clinical impairments and specific health conditions {#sec019}
---------------------------------------------------------------------

Overall, 8.4% (95% CI 7.5--9.4) in Cameroon and 10.5% (9.4--11.7) in India screened positive for one or more impairment/health condition ("clinical" cases) ([Table 4](#pone.0164470.t004){ref-type="table"}). Prevalence increased rapidly with age (data not shown). In both countries the most prevalent impairment across all ages was hearing impairment (Cameroon: 3.6% India: 4.4%), followed by MSI (Cameroon: 3.4% India: 3.5%), and visual impairment (Cameroon: 2.3% India: 3.5%).

3.4 Relationship between disability measurement approaches {#sec020}
----------------------------------------------------------

[Fig 2](#pone.0164470.g002){ref-type="fig"} describes the relationship between self-reported and clinical cases amongst the participants identified to have a disability.

![Relationship between disability measures in Cameroon and India.](pone.0164470.g002){#pone.0164470.g002}

One third (33%) of participants in Cameroon who were identified as having a disability, and 45% in India, were both self-reported cases and clinical cases (Category B).

A smaller proportion (Category A, 21% in Cameroon, and 14% in India) were self-reported cases, but not clinical cases. This category included people who (not mutually exclusive):

-   Screened positive for mild clinical impairments below the severity threshold defined as "clinical cases" (Cameroon: 41% of category, India: 74% of category).

-   Reported significant functional limitations in domains not directly screened clinically (e.g. remembering, concentrating) (Cameroon: 68%, India: 84%)

-   Reported functional limitations in domains which when evaluated clinically were found not to be impaired (e.g. hearing and walking) (Cameroon: 24%, India 41%)

Almost half of participants who were identified as having a disability in each setting (Cameroon: 47%, India: 41%), were clinical cases but not self-reported cases (Category C). The vast majority of people in this group reported at least "some" functional limitations in at least one domain, but no core domains in which they had "a lot of difficulty" or were "unable" to complete the activity (case definition for "self-reported case"). Amongst those in Category C this included: 93% of adults in both countries, 69% of children in Cameroon and 53% of children in India.

Expanding the case-definition for reported functional limitations to include either i)"some difficulty" in any basic domain, or ii)"some difficulty in any two domains" substantially increases the all-age prevalence of disability via self-report in Cameroon to 58.3% (95% CI 55.2--61.3) and 35.3% (32.7--38.1) respectively. In India, the prevalence of disability increased to 47.0% (44.0--50.1) and 27.6% (24.9--30.5) respectively. Expanding the case-definition to "some difficulty" in any basic domain would redefine 77.2% of Category C (clinical only) in Cameroon and 79.3% in India as Category B (clinical and self report) but would diminish Category B as a proportion to 12.7% (11.1--14.6) in Cameroon and and 20.4% (18.3--22.7) in India due to the large increase in Category A (self-report only).

[Table 5](#pone.0164470.t005){ref-type="table"} gives aggregate cross tabulations between clinical impairment severity in vision, hearing and MSI and the corresponding domains of the Washington Group (children 2--17: seeing, hearing, walking; adults: seeing, hearing, walking, upper body strength and fine motor skills). In both settings less than ten percent of participants reporting "no difficulties" were identified to have any level of impairment in the same domain. Approximately half of participants in India and one third in Cameroon who reported "some" difficulty in one of the domains directly measured clinically were determined to have a mild or above impairment. In addition, analysis for each of the three domains separately showed that this proportion ranged between less than twenty percent for sensory domains in both settings, and 22% (Cameroon) and 48% (India) in the physical domain in Cameroon and India respectively (data not shown).

10.1371/journal.pone.0164470.t005

###### Cross tabulation of clinical severity versus reported limitation[^1^](#t005fn001){ref-type="table-fn"}.

![](pone.0164470.t005){#pone.0164470.t005g}

                                             *Most severe clinical impairment*[^*2*^](#t005fn002){ref-type="table-fn"}                                                    
  ------------------------------------------ --------------------------------------------------------------------------- ------------ ---------- ---------- ------------- -------------
                                             India                                                                                                                        
  *Most significant functional limitation*   None                                                                        1769 (90%)   162 (8%)   16 (1%)    10 (1%)       1957 (100%)
  Some                                       499 (49%)                                                                   410 (40%)    82 (8%)    34 (3%)    1025 (100%)   
  A lot/ Can't do                            12 (5%)                                                                     43 (18%)     89 (38%)   92 (39%)   236 (100%)    
  Total                                      2280 (71%)                                                                  615 (19%)    187 (6%)   136 (4%)   3218 (100%)   
  Cameroon                                                                                                                                                                
  None                                       1555 (95%)                                                                  52 (3%)      33 (2%)    3 (1%)     1643 (100%)   
  Some                                       790 (68%)                                                                   247 (21%)    106 (9%)   16 (1%)    1159 (100%)   
  A lot/ Cant do                             28 (18%)                                                                    26 (17%)     64 (42%)   35 (23%)   153 (100%)    
  Total                                      2373 (80%)                                                                  325 (11%)    203 (7%)   54 (2%)    2955 (100%)   

^1^Combined cross-tabulation between i) any difficulty seeing, hearing, walking, upper body strength and motor skills and ii) any level visual, hearing or physical impairment. Restricted to age 5 and above based on severity data

^2^If multiple clinical impairments, most severe used in analysis.

^3^Cameroon missing hearing severity data for 23 participants excluded from analysis

In India, a single question "Do you consider yourself \[your child\] to have a disability" was included. Only 3.8% (95% CI 2.9--4.9) of the overall sample answered affirmatively. This included 25.5% of clinical cases, and 42.3% of self-reported cases (data not shown). Amongst those who answered "yes" to the single question, 14.1% were neither a self-reported nor clinical case.

3.5 Predictors of being a self-reported case amongst clinical cases {#sec021}
-------------------------------------------------------------------

[Table 6](#pone.0164470.t006){ref-type="table"} explores predictors amongst clinical cases of also being a self-reported case (Categories B and C).

10.1371/journal.pone.0164470.t006

###### Odds of reporting a functional limitation amongst participants screening positive for clinical impairments in Cameroon and India.
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                                                                         Cameroon   India                                                      
  ---------------------------------------------------------------------- ---------- ------- ----- ---- ----------------- ----- ---- ----- ---- -----------------
  **Age (years)**                                                                                                                              
  2--17                                                                  20         17      39    23   0.9 (0.3--2.7)    17    9    17    10   1.3 (0.6--2.9)
  18--33                                                                 12         10      17    10   1.3 (0.4--4.4)    19    9    21    12   1.0 (0.5--2.3)
  34--49                                                                 7          6       13    8    **baseline**      31    16   37    21   **baseline**
  50--65                                                                 19         16      27    16   1.4 (0.5--4.0)    72    37   76    43   1.1 (0.6--2.0)
  66+                                                                    60         51      72    43   1.5 (0.6--4.1)    60    31   25    14   2.9 (1.5--5.7)
  **Sex**                                                                                                                                      
  Male                                                                   50         42      61    36   **baseline**      83    42   90    51   **baseline**
  Female                                                                 68         58      107   64   0.8 (0.5--1.2)    114   58   86    49   1.4 (0.9--2.2)
  **Severity of impairment**[^**1**^](#t006fn001){ref-type="table-fn"}                                                                         
  Moderate                                                               73         65      136   90   **baseline**      95    49   108   73   **baseline**
  Severe                                                                 19         17      9     6    4.0 (1.7--9.4)    76    39   33    22   2.5 (1.5--4.1)
  Profound                                                               20         18      6     6    6.2 (2.4--16.3)   22    11   7     5    3.5 (1.4--8.8)
  **Type of impairment**[^**2**^](#t006fn002){ref-type="table-fn"}                                                                             
  Vision                                                                 12         10      35    21   **baseline**      28    14   48    28   **Baseline**
  Musculoskeletal                                                        39         33      39    23   3.1 (1.4--7.0)    41    21   16    9    4.8 (2.2--10.4)
  Hearing                                                                26         22      58    35   1.4 (0.6--3.1)    52    27   43    25   2.1 (1.1--4.0)
  Epilepsy                                                               1          1       16    10   0.2 (0.1--1.7)    4     2    38    22   0.2 (0.5--0.6)
  Multiple                                                               39         33      19    11   6.6 (2.7--15.9)   69    36   27    16   4.0 (2.0--7.7)

^1^Cameroon: missing severity data for 23 participants excluded; India: missing severity data for 29 participants excluded

^2^Depression excluded from analysis due to low number (n = 2 Cameroon, n = 7 India)

In India amongst clinical cases, adults aged ≥ 66years were more likely than adults aged 34--49 years to also be a self-reported case (OR 2.9, 95% CI 1.5--5.7). There was no association with age in Cameroon or sex in either setting. Clinical cases were more likely to also be self-reported cases if their impairments were severe (Cameroon: OR = 4.0, 95% CI 1.7--9.4, India: 2.5, 1.5--4.1) or profound (Cameroon: 6.2, 2.4--16.3, India: 3.5, 1.4--8.8) compared to moderate. Having multiple (Cameroon: 6.6, 2.7--15.9, India: 4.0, 2.0--7.7) or physical (Cameroon: 3.1, 1.4--7.0, India: 4.8, 2.2--10.4) impairments compared to vision impairment was also significantly associated with also being a self-reported case in both settings.

3.6 Participation restrictions among people with disabilities {#sec022}
-------------------------------------------------------------

[Table 7](#pone.0164470.t007){ref-type="table"} shows the maximum and mean participation scores for i) self-reported cases only (Category A), ii) self-reported and clinical cases (Category B) and iii) clinical cases only (Category C). Higher scores indicate greater participation restriction. We compared participation scores in i) Category A with Category B and ii) Category B with Category C, for adults (≥17 years) and children (5--16 years) separately. Among adults in both countries, participation restriction scores were significantly higher for Category B (self-report and clinical cases) compared to Category A (self-report cases only) and Category C (clinical cases only). In Cameroon, restrictions were slightly higher (p\<0.01) amongst Category C compared to Category A, but there was no difference between these categories in India. There was no difference in participation restriction by any case category amongst children in either country.

10.1371/journal.pone.0164470.t007

###### Participation restrictions amongst people with disabilities in Cameroon and India.
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                     Cameroon   India                                                                                                                                                                                                                           
  ------------------ ---------- ------------------------------------------- ------ ------ ------ ------------------------------------------- ----- ------------------------------------------- ------ ------ ------ ------------------------------------------- ------
  Children (5--16)   60         22.1                                        5.7    23.3   9.5    18.3                                        5.2   40.0                                        18.2   28.6   12.2   20.7                                        9.9
  Adults (17+)       84         26.7[\*](#t007fn001){ref-type="table-fn"}   13.6   38.1   13.6   31.2[\*](#t007fn001){ref-type="table-fn"}   9.1   36.1[\*](#t007fn001){ref-type="table-fn"}   15.3   45.9   16.2   34.3[\*](#t007fn001){ref-type="table-fn"}   11.9

\*P\<0.01 from independent t-test comparing i) Category A vs B and ii) Category B vs C

^1^NB Higher scores denote greater participation restrictions

Discussion {#sec023}
==========

4.1 Summary of results {#sec024}
----------------------

The overall disability prevalence estimated in the study was 10.5% (95% CI 9.0--12.2) in Cameroon and 12.2% (10.6--14.1) in India, reflecting all participants who either self-reported significant functional limitation (5.9% \[4.7--7.4\] in Cameroon and 7.5% \[5.9--9.4\] in India) or screened positive clinically to a moderate or severe impairment or disabling health condition (8.4% \[7.5--9.4\] in Cameroon and 10.5% \[9.4--11.7\] in India). As expected, disability prevalence in both countries increased exponentially with age, irrespective of how disability was measured. Use of a single question on disability in India identified less than one third (26.5%) of those otherwise classed as having a disability.

These figures are higher than other country prevalence estimates of disability. In Cameroon, the 2011 Demographic and Health Survey estimated an all-age prevalence of 5.4%, whilst a 2010 study by Cockburn et al. in North-West Cameroon estimated a regional prevalence of 6.2%\[[@pone.0164470.ref035], [@pone.0164470.ref036]\]. However, both studies used measures of self-reported functional limitation only, showing similarity with the self-report estimates in the present study. In India, the 2011 country census estimated a country-wide prevalence of 2.2%, using a single disability screening question with multiple "type of disability" response categories. This is consistent with our finding that use of a single question on disability in India identified fewer than one third of those otherwise defined as having a disability. Moreover, the similarity of findings across both countries reflects a consistency and standardisation of the methods used.

Very few previous studies have considered the agreement between measures of self-reported functional limitations and clinical screening. One study by Kempen et al. (1996) found discrepancies between self-reported and performance-based motor and sensory limitations amongst the elderly, related to socio-demographic factors and personality traits \[[@pone.0164470.ref037]\]. Our study showed a considerable lack of overlap between the people identified as having a disability via reported functional limitation and via clinical screening. Many who reported significant limitations only (Category A) either had mild clinical impairments or reported limitations not directly screened clinically. Amongst those who screened positive clinically only (Category C), the vast majority had reported "some" difficulty in at least one functioning domain, but no domains with "a lot of difficulty" or "cannot do" (the case definition for self-reported limitations. However, incorporating "some difficulty" into the threshold for significant functional limitation further widened the discrepancy between measures through large inflation of Category A, increasing the overall prevalence of disability to approximately half the population. Further, our data showed that considering those self-reported domains which were directly screened clinically (vision, hearing and physical) 40% of participants who reported "some" difficulty in seeing, hearing or walking/upper body strength/fine motor skills in India, and 21% in Cameroon screened positive for mild impairments, whilst half in India and two thirds in Cameroon were not identified to have any level of impairment in the corresponding impairment categories.

In adults, participation restrictions were highest amongst those who both screened positive for clinical impairments and reported significant functional limitations (Category B), although there was no relationship by case category in children.

4.2 Implications of findings {#sec025}
----------------------------

The disparity between the sub-populations identified using a reported functional limitation tool and a battery of impairment screens has several major implications.

Firstly, this result provides evidence that clinical impairment tools in isolation do not adequately capture all significant functional limitations, with 21% of those with disability in Cameroon and 14% of those in India not identified via clinical tools.

Secondly, that 46% of those considered to have a disability in Cameroon and 41% in India, were identified via objective clinical measures but did not report a significant functional limitation and would therefore be missed by surveys using reported functioning tools only. Specifically, participants with moderate impairments or impairments in vision or hearing, were less likely to self-report functional limitations. From the perspective of universal health coverage and delivery of health and rehabilitative interventions, this may be inadequate. Several studies have highlighted the "hierarchy" of disability \[[@pone.0164470.ref038], [@pone.0164470.ref039]\]. Namely, that impairments considered less critical to the individual's participation, may not be reported. This is shown in the current study in that participants with physical impairments in both study settings (both predominantly agricultural) were far more likely to report a significant limitation in functioning in the corresponding domain (walking and climbing) than participants with vision or hearing impairments. Moreover, this suggests that not all participants with impairments affecting their functioning or participation report these limitations/restrictions. If this is the case, surveys using self-reported tools only may underestimate disability.

Thirdly, our study adds to the considerable ongoing debate related to appropriate measures for population-based disability measurement within the ICF, and the theoretical basis for determining the population of interest \[[@pone.0164470.ref040], [@pone.0164470.ref041]\]. It is imperative to acknowledge that disability is an umbrella concept and that measurement at the level of impairments, activity limitations or participation restrictions, and the triangulation of these tools, will identify different samples. The United Nations Convention on the Rights of Persons with Disabilities (UNCRPD) defines disability as "an evolving concept that \[..\] results from the interaction between persons with impairments and attitudinal and environmental barriers that hinders their full and effective participation in society on an equal basis with others"\[[@pone.0164470.ref042]\]. Considering this as our population of interest, our findings suggest that using a self-reported tool in isolation is perhaps too restrictive at the level of "a lot" and too broad at the level of "some" to determine this sub-population, but that a self-reported tool with additional clinical screens for all who report "some" difficulty will identify the vast majority of people who experience either a moderate or greater clinical impairment, or participation restriction.

One solution, where resources allow, might therefore be to screen populations first with the Washington Group Questions to measure the magnitude of significant functional limitations ("a lot of difficulty" or "cannot do") and provide a comparable estimate of disability between countries and over time. Secondly, a simple clinical screen could be administered to all participants who respond to having at least "some" difficulty in a specific domain so that all moderate/severe impairments are identified and the appropriate referrals to maximise functioning offered. This approach would identify 94% of people with disabilities in Cameroon and 95% in India, based on the present study criteria, although further work is needed to address screening for mental health disorders and cognitive impairments. The use of mid-level clinicians as opposed to specialists in this study increases the feasibility of this approach. In addition, recent innovations in mobile tools for impairment screening would decrease the burden on clinical team members, who would only need to visit participants failing the screen criteria to provide any diagnosis or referral as appropriate \[[@pone.0164470.ref043], [@pone.0164470.ref044]\]. Finally, this data could be triangulated with a tool to measure participation restrictions and external barriers in order to provide more contextual information about the lives of people with disabilities. Further development of such tools and this methodology is needed.

We acknowledge that the lack of clinical screens for common mental disorders (other than depression), and for cognitive impairment, makes a comprehensive exploration of tools to measure disability difficult to achieve. This is a critical limitation in the field of disability measurement, particularly in a survey setting, and is considered a priority by leading scholars in global mental health \[[@pone.0164470.ref025], [@pone.0164470.ref045]--[@pone.0164470.ref047]\].

It is also important to acknowledge that different methodologies impact on comparability of disability prevalence estimates and available information, even within the broader classification of self-reported functioning tools. Multiple international agencies, including several United Nations agencies, have agreed to endorse the "short-set" Washington Group Questions for upcoming data collection. However, work is ongoing to further develop and finalise other tools, including the Washington Group Extended Set used in this study and the Model Disability Survey (developed after our study was conducted) \[[@pone.0164470.ref048]\]. Future research should consider similar triangulation of these tools with both clinical tools and tools to evaluate participation restriction, so as to assess comprehensive compatibility with the ICF.

4.3 Study Strengths and limitations {#sec026}
-----------------------------------

The study used a robust sampling methodology to provide estimates of disability compatible with the ICF. The study measured and compared the relationship between different components of disability, adding to the evidence base in this important measurement area.

However, tools and diagnostic tests for assessing mental health and cognitive impairments in this study were limited. The findings of the present study will be used to inform the Washington Group Working Group on Mental Health and further this goal.

Finally, PTA and OAE testing was affected particularly in Cameroon by environmental conditions and consistently high background noise, increasing the risk of false positives.

Conclusion {#sec027}
==========

Tools to assess reported functional limitation alone are insufficient to identify all persons with moderate or severe clinical impairments that impact on participation. A self- reported tool followed by clinical screening of all those who report "some difficulty" in functioning would identify 94% of people with disabilities in Cameroon and 95% in India, based on the study criteria. This would allow data to be collected using the internationally agreed and comparable standard (self-report) whilst also ensuring adequate information on impairments and participation restrictions for service provision. However, further work is needed on field tools for assessment of common mental disorders and cognitive impairment to comprehensively assess disability within the ICF.
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